BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 31497851)

  • 1. Stress-induced remodelling of the mitral valve: a model for leaflet thickening and superimposed tissue formation in mitral valve disease.
    Kruithof BPT; Paardekooper L; Hiemstra YL; Goumans MJ; Palmen M; Delgado V; Klautz RJM; Ajmone Marsan N
    Cardiovasc Res; 2020 Apr; 116(5):931-943. PubMed ID: 31497851
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Deletion of Fstl1 (Follistatin-Like 1) From the Endocardial/Endothelial Lineage Causes Mitral Valve Disease.
    Prakash S; Borreguero LJJ; Sylva M; Flores Ruiz L; Rezai F; Gunst QD; de la Pompa JL; Ruijter JM; van den Hoff MJB
    Arterioscler Thromb Vasc Biol; 2017 Sep; 37(9):e116-e130. PubMed ID: 28705792
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative pathology of human and canine myxomatous mitral valve degeneration: 5HT and TGF-β mechanisms.
    Oyama MA; Elliott C; Loughran KA; Kossar AP; Castillero E; Levy RJ; Ferrari G
    Cardiovasc Pathol; 2020; 46():107196. PubMed ID: 32006823
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative Histopathological Analysis of Mitral Valves in Barlow Disease and Fibroelastic Deficiency.
    Hjortnaes J; Keegan J; Bruneval P; Schwartz E; Schoen FJ; Carpentier A; Levine RA; Hagège A; Aikawa E
    Semin Thorac Cardiovasc Surg; 2016 Winter; 28(4):757-767. PubMed ID: 28417861
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biomechanical evaluation of the pathophysiologic developmental mechanisms of mitral valve prolapse: effect of valvular morphologic alteration.
    Choi A; McPherson DD; Kim H
    Med Biol Eng Comput; 2016 May; 54(5):799-809. PubMed ID: 26307201
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mitral Leaflet Changes Following Myocardial Infarction: Clinical Evidence for Maladaptive Valvular Remodeling.
    Beaudoin J; Dal-Bianco JP; Aikawa E; Bischoff J; Guerrero JL; Sullivan S; Bartko PE; Handschumacher MD; Kim DH; Wylie-Sears J; Aaron J; Levine RA
    Circ Cardiovasc Imaging; 2017 Nov; 10(11):. PubMed ID: 29042413
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gross and histological features of excised portions of posterior mitral leaflet in patients having operative repair of mitral valve prolapse and comments on the concept of missing (= ruptured) chordae tendineae.
    Roberts WC; Vowels TJ; Ko JM; Hebeler RF
    J Am Coll Cardiol; 2014 Apr; 63(16):1667-74. PubMed ID: 24316086
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human myxomatous mitral valve prolapse: role of bone morphogenetic protein 4 in valvular interstitial cell activation.
    Sainger R; Grau JB; Branchetti E; Poggio P; Seefried WF; Field BC; Acker MA; Gorman RC; Gorman JH; Hargrove CW; Bavaria JE; Ferrari G
    J Cell Physiol; 2012 Jun; 227(6):2595-604. PubMed ID: 22105615
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serotonin receptor 2B signaling with interstitial cell activation and leaflet remodeling in degenerative mitral regurgitation.
    Driesbaugh KH; Branchetti E; Grau JB; Keeney SJ; Glass K; Oyama MA; Rioux N; Ayoub S; Sacks MS; Quackenbush J; Levy RJ; Ferrari G
    J Mol Cell Cardiol; 2018 Feb; 115():94-103. PubMed ID: 29291394
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A New Role for the Aldosterone/Mineralocorticoid Receptor Pathway in the Development of Mitral Valve Prolapse.
    Ibarrola J; Garcia-Peña A; Matilla L; Bonnard B; Sádaba R; Arrieta V; Alvarez V; Fernández-Celis A; Gainza A; Navarro A; Alvarez de la Rosa D; Rossignol P; Jaisser F; López-Andrés N
    Circ Res; 2020 Jul; 127(3):e80-e93. PubMed ID: 32329663
    [TBL] [Abstract][Full Text] [Related]  

  • 11. TGF-beta-dependent pathogenesis of mitral valve prolapse in a mouse model of Marfan syndrome.
    Ng CM; Cheng A; Myers LA; Martinez-Murillo F; Jie C; Bedja D; Gabrielson KL; Hausladen JM; Mecham RP; Judge DP; Dietz HC
    J Clin Invest; 2004 Dec; 114(11):1586-92. PubMed ID: 15546004
    [TBL] [Abstract][Full Text] [Related]  

  • 12. TGF-β signalling and reactive oxygen species drive fibrosis and matrix remodelling in myxomatous mitral valves.
    Hagler MA; Hadley TM; Zhang H; Mehra K; Roos CM; Schaff HV; Suri RM; Miller JD
    Cardiovasc Res; 2013 Jul; 99(1):175-84. PubMed ID: 23554457
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Emerging pathogenic mechanisms in human myxomatous mitral valve: lessons from past and novel data.
    Hulin A; Deroanne C; Lambert C; Defraigne JO; Nusgens B; Radermecker M; Colige A
    Cardiovasc Pathol; 2013; 22(4):245-50. PubMed ID: 23261354
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transesophageal echocardiographic assessment of the contribution of intrinsic tissue thickness to the appearance of a thick mitral valve in patients with mitral valve prolapse.
    Louie EK; Langholz D; Mackin WJ; Wallis DE; Jacobs WR; Scanlon PJ
    J Am Coll Cardiol; 1996 Aug; 28(2):465-71. PubMed ID: 8800127
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modulation of transforming growth factor-β signaling and extracellular matrix production in myxomatous mitral valves by angiotensin II receptor blockers.
    Geirsson A; Singh M; Ali R; Abbas H; Li W; Sanchez JA; Hashim S; Tellides G
    Circulation; 2012 Sep; 126(11 Suppl 1):S189-97. PubMed ID: 22965982
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of canine 2D cell cultures as models of myxomatous mitral valve degeneration.
    Tan K; Markby G; Muirhead R; Blake R; Bergeron L; Fici G; Summers K; Macrae V; Corcoran B
    PLoS One; 2019; 14(8):e0221126. PubMed ID: 31415646
    [TBL] [Abstract][Full Text] [Related]  

  • 17. TGF-beta1 pathway activation and adherens junction molecular pattern in nonsyndromic mitral valve prolapse.
    Rizzo S; Basso C; Lazzarini E; Celeghin R; Paolin A; Gerosa G; Valente M; Thiene G; Pilichou K
    Cardiovasc Pathol; 2015; 24(6):359-67. PubMed ID: 26345253
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Loss of Axin2 results in impaired heart valve maturation and subsequent myxomatous valve disease.
    Hulin A; Moore V; James JM; Yutzey KE
    Cardiovasc Res; 2017 Jan; 113(1):40-51. PubMed ID: 28069701
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical and pathological features of degenerative mitral valve disease: billowing mitral leaflet versus fibroelastic deficiency.
    Matsumaru I; Eishi K; Hashizume K; Kawano H; Tsuneto A; Hayashi T
    Ann Thorac Cardiovasc Surg; 2014; 20(6):987-94. PubMed ID: 24284503
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Unravelling the proteome of degenerative human mitral valves.
    Tan HT; Lim TK; Richards AM; Kofidis T; Teoh KL; Ling LH; Chung MC
    Proteomics; 2015 Sep; 15(17):2934-44. PubMed ID: 25914152
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.